China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.50+0.02 (+4.17%)
Close on Nov 17, 2026Market cap $21.51MP/E –Yield –
China Pharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
China Pharma's revenue for the twelve months ending Jun 30, 2026 was $3.91M, down 11.0% year over year. For fiscal 2025 it was $4.14M, down 8.5% from the year before. Over ten years it grew -14.7% a year on average. The highest annual figure on record is $81.17M in fiscal 2011.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14M | -8.5% |
| FY2024 | Dec 31, 2024 | $4.53M | -35.4% |
| FY2023 | Dec 31, 2023 | $7.01M | -13.5% |
| FY2022 | Dec 31, 2022 | $8.10M | -15.9% |
| FY2021 | Dec 31, 2021 | $9.64M | -11.3% |
| FY2020 | Dec 31, 2020 | $10.87M | -0.5% |
| FY2019 | Dec 31, 2019 | $10.92M | -11.4% |
| FY2018 | Dec 31, 2018 | $12.33M | -6.7% |
| FY2017 | Dec 31, 2017 | $13.21M | -15.1% |
| FY2016 | Dec 31, 2016 | $15.57M | -23.5% |
| FY2015 | Dec 31, 2015 | $20.35M | -8.1% |
| FY2014 | Dec 31, 2014 | $22.13M | -32.5% |
| FY2013 | Dec 31, 2013 | $32.81M | -39.8% |
| FY2012 | Dec 31, 2012 | $54.51M | -32.8% |
| FY2011 | Dec 31, 2011 | $81.17M | +9.1% |
| FY2010 | Dec 31, 2010 | $74.39M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $948.34K | -7.5% |
| Q1 FY2026 | Mar 31, 2026 | $983.54K | -13.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.23M | +8.1% |
| Q3 FY2025 | Sep 30, 2025 | $756.22K | -31.3% |
| Q2 FY2025 | Jun 30, 2025 | $1.03M | +10.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.14M | -17.0% |
| Q4 FY2024 | Dec 31, 2024 | $1.13M | -47.2% |
| Q3 FY2024 | Sep 30, 2024 | $1.10M | -39.0% |
| Q2 FY2024 | Jun 30, 2024 | $924.94K | -15.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.37M | -30.1% |
| Q4 FY2023 | Dec 31, 2023 | $2.15M | -26.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.80M | -8.3% |
| Q2 FY2023 | Jun 30, 2023 | $1.10M | -31.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.96M | +22.2% |
| Q4 FY2022 | Dec 31, 2022 | $2.92M | +1.1% |
| Q3 FY2022 | Sep 30, 2022 | $1.97M | -0.6% |
| Q2 FY2022 | Jun 30, 2022 | $1.61M | -33.2% |
| Q1 FY2022 | Mar 31, 2022 | $1.60M | -32.0% |
| Q4 FY2021 | Dec 31, 2021 | $2.89M | -1.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.98M | -17.6% |
| Q2 FY2021 | Jun 30, 2021 | $2.42M | -35.9% |
| Q1 FY2021 | Mar 31, 2021 | $2.36M | +33.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.93M | -3.8% |
| Q3 FY2020 | Sep 30, 2020 | $2.40M | +1.0% |
| Q2 FY2020 | Jun 30, 2020 | $3.77M | +46.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.76M | -39.8% |
| Q4 FY2019 | Dec 31, 2019 | $3.05M | -6.0% |
| Q3 FY2019 | Sep 30, 2019 | $2.38M | +3.4% |
| Q2 FY2019 | Jun 30, 2019 | $2.57M | -19.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.93M | -19.0% |
| Q4 FY2018 | Dec 31, 2018 | $3.24M | -15.7% |
| Q3 FY2018 | Sep 30, 2018 | $2.30M | -27.3% |
| Q2 FY2018 | Jun 30, 2018 | $3.17M | +8.8% |
| Q1 FY2018 | Mar 31, 2018 | $3.62M | +10.1% |
| Q4 FY2017 | Dec 31, 2017 | $3.85M | -26.9% |
| Q3 FY2017 | Sep 30, 2017 | $3.16M | +1.2% |
| Q2 FY2017 | Jun 30, 2017 | $2.92M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.29M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.26M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.13M | – |
See a number that looks wrong?